Curosurf

Curosurf (Poractant Alfa) is a natural surfactant used for respiratory support in premature infants. This product helps improve lung function and reduce respiratory distress. Learn more about its uses and benefits.

Curosurf is primarily used to treat respiratory distress syndrome (RDS) in premature infants. It works by replacing the natural surfactant in the lungs, which helps the lungs expand more easily. This medication is administered via endotracheal tube directly into the lungs. Curosurf is often used in neonatal intensive care units (NICUs) to support breathing in premature babies.

Curosurf helps to reduce the surface tension in the lungs, making it easier for the infant to breathe. This can lead to improved oxygen levels and reduced need for mechanical ventilation. The effects of Curosurf are typically seen shortly after administration, providing immediate respiratory support.

Curosurf should be administered by trained healthcare professionals in a controlled medical setting. It is important to follow proper handling and storage guidelines to maintain its effectiveness. Always consult with a healthcare provider for specific precautions and contraindications.

Curosurf is generally well-tolerated, but interactions with other medications should be monitored. It is important to inform healthcare providers about all medications the infant is taking. Always follow the advice of a healthcare professional regarding potential interactions.